Almac Clinical Technologies’ cover photo
Almac Clinical Technologies

Almac Clinical Technologies

Pharmaceutical Manufacturing

Souderton, Pennsylvania 1,807 followers

Empowering clinical trial sponsors to proactively manage sites, patients and clinical trial supplies.

About us

About IXRS®3 - The #1 Patient Randomisation and Clinical Supply Management Platform - Configurable core: choose from three start-up modes to fit your study's needs and protocol requirements - Never get locked in: IXRS®3 grows with your study. Add new sites, patients, and features at any time - IRT Suite includes DCT support, biostatistical services, adaptive trial designs, accountability and reconciliation tracking, advanced data visualisations, analytics, and reporting - Global coverage, 65+ supported languages, 10,000 site activations per year About Almac Clinical Technologies - 25+ years of dedicated IRT experience - 700+ employees - Offices in UK, US, Tokyo, and Singapore Almac Clinical Technologies is a part of Almac Group - a privately owned, global drug development services provider. Almac Group is an established, leading contract development and manufacturing organisation with a strong reputation for innovation, quality, and customer service. We provide an extensive range of integrated services to 600+ biopharma companies globally. 

Industry
Pharmaceutical Manufacturing
Company size
1,001-5,000 employees
Headquarters
Souderton, Pennsylvania
Specialties
Interactive Response Technology, IRT, Randomisation and Trial Supply Management, RTSM, eClinical, Clinical Technology, Study Maintenance, Clinical Integrated Services, Biostatistical Services, Drug Reconciliation, Data Integration, Drug Accountability, and Clinical Supply Chain Management

Updates

Affiliated pages

Similar pages